Medical Captive Underwriters

  • ClearCaptive
    • Why ClearCaptive
    • National Support
  • What We Do
  • Resources
    • Industry Resources
  • Who We Are
  • Contact
  • Blog
  • ClearCaptive
    • Why ClearCaptive
    • National Support
  • What We Do
  • Resources
    • Industry Resources
  • Who We Are
  • Contact
  • Blog

blog

The ACA mandates a contract HIT on employer profitability, employee retention and recruitment

10/22/2019

0 Comments

 
Picture
​Middle market employers gain control and transparency by transitioning to self-funding (SF) utilizing a group captive program.  Control over the Plans offered; Transparency over all aspects of the what drives the renewal cost.  Said another way, do away with arbitrary overhead charges, undisclosed costs and RX revenue to the fully insured (FI) carrier. The FI carrier unilaterally changes the Plan (not offered this year?) misstating the actual impact of the FI renewal.  SF renewals are easier at open enrollment, employers can choose to leave the Plans in place.  The conversation is the change in employee and member contribution.  FI overhead is subject to Medical Loss Ratio (MLR).  The 15-20% MLR ignores fees and rebates FI carriers add or receive that do not require disclosure.  Increasing FI profitability year over year.  Prior to passage of the Affordable Care Act (ACA), the SF transition conversation centered on removal of state mandated coverage and premium taxes.  The conversation today expands to include ACA Health Insurance Taxes (HIT) and the gerrymandered MLR.  

The ACA imposes an annual, non-deductible cost on insurance companies that offer FI plans and other providers of health coverage – the “HIT”. This ACA fee was intended to fund the state and federal ACA marketplace. The fee is based on an insurer’s share of the market, which is calculated based on each insurer’s net premiums for the year. The estimated applicable amount to be allocated between the FI market in 2020 exceeds $15,500,000,000. ACA requires the fee be paid in each calendar year after 2013. Legislation enacted in December 2015 suspended HIT collection for 2017.  January 2018 legislation suspended the HIT collection for 2019. Unless Congress acts, the fee will go into effect for 2020. Even if congress acts shortly, can you expect your locked rates to be reduced by the FI market to offset removal of the HIT mandate?
 
The annual HIT fee is assessed and paid on a calendar-year basis, based on data from the prior year. Next year the HIT fee is due September 30, 2020, based on 2019 data. Only FI carriers and providers of similar coverage pay the HIT fee. FI carriers pass the HIT tax to employer group clients in the form of higher market premiums. The increased HIT amount will likely result in plan premium increases for 2020, adding roughly 3% to the overall premium costs. Plan sponsors should be aware this fee may be reflected in their 2020 FI premiums. 

Middle market employers self-funding utilizing a group captive gain transparency and control while avoiding HIT, certain state premium taxes, some state coverage mandates, undisclosed RX rebates and the overall lack of transparency in the FI market.
Don McCully runs Medical Captive Underwriters LLC, www.medicalcaptive.com - Program management company using alternative risk transfer solutions lowering employer’s costs in both A&H and P&C insurance. Primary focus today is employee benefit advisors to lower medical spend and medical trend for employers enrolled in ClearCaptive. ClearCaptive is a 50 state open access, stop-loss captive solution for middle market employers with at least 50 enrolled employees.
0 Comments

Plan Sponsors:  Group captive versus level-funding:  Cash matters

10/14/2019

0 Comments

 
Picture
Plan Sponsors considering or reviewing your Group Stop-loss Captive program: Does cash matter?
Middle-market employer plan sponsors choose a group stop-loss captive over fully funded options for a variety of reasons. Increased data transparency derived from self-funding delivers more accurate measurements of medical spend reporting to apprise management of this unremittingly increasing expense item. Increased medical expense reduces cash liquidity on a self-funded plan sponsor’s balance sheet, especially when revenue does not grow enough to offset the rate (5.8%) of annual medical inflation over the past decade.
Medical inflation grew at twice the yearly US inflation rate during this time period and is driven largely by the costs of specialty pharmaceuticals which are growing at an unprecedented rate.  Also contributing are increased instances of catastrophic claims over $1 million, which have grown more than 30% annually in each of the last eight years. The growth rates in these two categories are exacerbated by the addition of fully insured carriers adding overhead and other ambiguous expense fees to their premiums. Fully insured carriers make nearly ten times the profit compared to independent, unbundled stop-loss carriers.
Self-funding through a group stop-loss captive effectively lowers an employer’s costs as insurance carrier overhead, administrative fees, state premium taxes and ACA assessments are not a component of the plan sponsors directly paid RX and medical spend. Self-funding delivers a lower overall cost structure which contributes to increased asset liquidity on the employer’s balance sheet. Employer control over the plan agility is also accentuated as most plan assets are controlled by the self-insured employer plan sponsor.
Greater control to increase transparency and reduce costs are primary reasons that self-funding through a group stop loss captive is a preferred option for middle-market employers to more effectively manage this important income statement expense. A tradeoff however, for enrolling in a group captive program is the requirement to post collateral, typically in the form of cash or a letter of credit, to secure their portion of “insurance company” obligations assumed by the captive. In return, employers can expect reduced benefit costs and the opportunity receive dividend distributions from their participation in the shared profitability of the captive.
Profitability dividends delivered by the captive serve to effectively lower overall medical benefit spend. An example of a successful underwriting year is an employer receiving a 5% of premium return in the form of a dividend distribution from the captive. In this example, the employer posts 10% of premium in the form of collateral. The employer received a one year, 50% return on capital (collateral). It is important to note that receiving profitability distributions from the captive/shared risk layer are not guaranteed and posted collateral is also at risk of a partial or even full loss.
Cash does matter! The amount of collateral required, the number of underwriting years that collateral funds will be held, along with the percentage and frequency of dividends returned by the captive all need to be appropriately understood by the employer. Does the group stop-loss captive have a consistent history of returning profitability distributions? What is the captive program’s frequency of providing dividend distributions? Every three years, every other year or four out of five years? The experience of the underwriter combined with employer participation in initiatives that influence reductions to medical and pharmacy costs will contribute to the increased potential for delivering underwriting profit.
No two programs are the same. Each employer is unique, just like each group stop-loss captive program is unique. Lowering the ultimate cost of delivering healthcare benefits to employees is a primary objective for participating in a group stop loss captive. The program should empower an employer with increased ability to control this expense line item on their income statement and improve balance sheet liquidity. Success can be measured by reducing insurance expenses, retaining more cash and receiving profitability distributions associated with an appropriate sharing and spreading of risk.
​
Don McCully runs Medical Captive Underwriters LLC, (www.medicalcaptive.com). A program management company focused on alternative risk transfer solutions to lower employer’s costs in both accident and health & property and casualty insurance. Primary focus today is employee benefit advisors assisting them to lower medical spend and medical trend for employers enrolled in ClearCaptive. ClearCaptive is a 50 state open, stop-loss captive solution for middle market employers above 50 employees enrolled on the Plan.
0 Comments

The devil is in the details - stop-loss contracts!

9/10/2019

0 Comments

 
Picture
​
Picture
The devil is in the details – stop-loss contracts!
TRUE STORIES – Claims over Individual Specific Limit presented more than 6 months after treatment ended:   A) Sepsis treated in hospital environment > $1mm.  B) Injury to chest at home >$250k.
Scenario 1 – Employer renewal utilized a 12/15 or 12/18.  Claim presented outside contract terms, no reimbursement to employer for claim. 12/15 and 12/18 contracts annually both over and under insure an employer.  
 Scenario 2 – Employer renews utilizing a 12/24.   Claim is not paid in the current term, paid if the previous contract is also a 12/24.  Better coverage with less gaps than a 12/15 or 12/18.  Delays premium return if employer is part of a medical stop-loss group captive.
The truth – Claims are both paid under the 24/12 contract purchased from their carrier.   At Renewal employers move to a 36/12, extending the reporting period to present claims for reimbursement.  In both example A and B above, the employer received a distribution of premium from 2018 underwriting year in August, 2019.  Terminal Liability remains available in renewal contracts.
Employers enrolling in medical group stop-loss captive programs understand the program goals and outcomes as reflected in the materials explaining the value proposition from the captive program sponsor.  The programs are all based on the law of large numbers.  The program intentions may include some or all the following:
-smoothing renewals                     
 lowering medical spend             
-lowering medical trend               
​-preserving employer’s investment or collateral (program sponsor’s choice of words)    
The stop-loss contract is the first document that determines how and when claims are reimbursed, based on the employer’s Signed Plan Document.  Direct write carriers reimburse claims quickly, once the claim is accepted.  Usually less than 7-12 business days.  This is true whether the carrier purchases reinsurance or not (carriers typically buy reinsurance at $2,000,000 over the employer’s Individual Specific Limit).    
Managing General Underwriters (MGU) claims authority is tied to the MGU’s excess of loss reinsurer. This extends the claims reimbursement timing to the employer. A second set of eyes reviews every claim reimbursed above employer’s individual specific limit. 
Until the passage of the Affordable Care Act (ACA), which coincided with the market expansion of group captives utilizing stop-loss, specific claims largely fell below $1,000,000.  The ACA increased claims limits, empowering specialty pharmacy and hospital to increase their charges due to the removal of annual caps.
Does your stop-loss contract meet the needs of today’s ever evolving claims environment?  An employer purchasing stop-loss expects reimbursement of claims based on the Signed Plan Document.

Don McCully runs Medical Captive Underwriters LLC, (www.medicalcaptive.com).  A program management company focused on alternative risk transfer solutions to lower employer’s costs in both accident and health & property and casualty insurance. ClearCaptive is a 50 state open access, group stop-loss captive solution for middle market employers above 50 employees 

0 Comments

Self Insurance Institute of America: 39th Annual National Education Conference

8/27/2019

0 Comments

 
Picture
0 Comments

Does cash matter?  A timely question for Plan Sponsors enrolled in a group stop loss captive program.

8/19/2019

0 Comments

 
Picture
Picture


Middle-market employer plan sponsors choose a group stop-loss captive over fully funded options for a variety of reasons.  Increased data transparency derived from self-funding delivers more accurate measurements of medical spend reporting to apprise management of this unremittingly increasing expense item.   Increased medical expense reduces cash liquidity on a self-funded plan sponsor’s balance sheet, especially when revenue does not grow enough to offset the rate (5.8%) of annual medical inflation over the past decade.

Medical inflation grew at twice the yearly US inflation rate during this time period and is driven largely by the costs of specialty pharmaceuticals which are growing at an unprecedented rate.  Also contributing are increased instances of catastrophic claims over $1 million, which have grown more 
than 30% annually in each of the last eight years.  The growth rates in these two categories are exacerbated by the addition of fully insured carriers adding overhead and other ambiguous expense fees to their premiums.  Fully insured carriers make nearly ten times the profit compared to independent, unbundled stop-loss carriers.

Self-funding through a group stop-loss captive effectively lowers an employer’s costs as insurance carrier overhead, administrative fees, state premium taxes and ACA assessments are not a component of the plan sponsors directly paid RX and medical spend.  Self-funding delivers a lower overall cost structure which contributes to increased asset liquidity on the employer’s balance sheet.  Employer control over the plan agility is also accentuated as most plan assets are controlled by the self-insured employer plan sponsor.

Greater control to increase transparency and reduce costs are primary reasons that self-funding through a group stop loss captive is a preferred option for middle-market employers to more effectively manage this important income statement expense.  A tradeoff however, for enrolling in a group captive program is the requirement to post collateral, typically in the form of cash or a letter of credit, to secure their portion  of “insurance company” obligations assumed by the captive.  In return, employers can expect reduced benefit costs and the opportunity receive dividend distributions from their participation in the shared profitability of the captive.

Profitability dividends delivered by the captive serve to effectively lower overall medical benefit spend. An example of a successful underwriting year is an employer receiving a 5% of premium return  in the form of a dividend distribution from the captive.  In this example, the employer posts 10% of premium in the form of collateral.  The employer received a one year, 50% return on capital (collateral). It is important to note that receiving profitability distributions from the captive/shared risk layer are not guaranteed and posted collateral is also at risk of a partial or even full loss.

Cash does matter! The amount of collateral required, the number of underwriting years that collateral funds will be held, along with the percentage and frequency of dividends returned  by the captive all need to be appropriately understood by the employer.  Does the group stop-loss captive have a consistent history of returning profitability distributions?   What is the captive program’s frequency of providing dividend distributions? Every three years, every other year or four out of five years? The experience of the underwriter combined with employer participation in initiatives that influence reductions to medical and pharmacy costs will contribute to the increased potential for delivering underwriting profit.

No two programs are the same.  Each employer is unique, just like each group stop-loss captive program is unique.  Lowering the ultimate cost of delivering healthcare benefits to employees is a primary objective for participating in a group stop loss captive.  The program should empower an employer with increased ability to control this expense line item on their income statement and improve balance sheet liquidity. Success can be measured by reducing insurance expenses, retaining 
more cash and receiving profitability distributions associated with an appropriate sharing and spreading of risk.

Don McCully runs Medical Captive Underwriters LLC, (www.medicalcaptive.com).  A program management 
company focused on alternative risk transfer solutions to lower employer’s costs in both accident 
and health & property and casualty insurance.  Primary focus today is employee benefit advisors 
assisting them to lower medical spend and medical trend for employers enrolled in ClearCaptive.  
ClearCaptive is a 50 state open, stop-loss captive solution for middle market employers above 50 employees enrolled on the Plan.

0 Comments

MRI and x-rays adversely impact claims cost and the potential for an opioid prescription.

8/8/2019

0 Comments

 
Picture
An MRI or X-ray reflecting no musculoskeletal damage may lead to an unnecessary painkiller prescription.  A surgery where an incorrect body part is operated on falls under the heading of malpractice; but what is the classification for an unnecessary surgical procedure or prescription?  How many unnecessary surgeries could be avoided with a treatment plan that is focused on return-to-work protocols or physical rehabilitation.   Prescription (RX) utilization and MRI/X-ray scan costs are reduced when noninvasive alternative therapies are included by a plan sponsor as the recommended initial approach.  
Twenty percent of the U.S. Gross Domestic Product is devoted to healthcare.  Ninety percent of MRI’s and X-rays may be unnecessary as they will only indicate a bone, ligament or tendon issue and are unable to detect soft-tissue muscle problems.  Prescriptions for opioid pain relievers are fairly common following an MRI or X-ray.  Frequently, a patient experiencing soft-tissue pain is better served with a lower cost and non-addictive pain solution such as ice and Ibuprofen.  
There are an increasing variety of innovative solutions for reducing medical and pharmacy costs. The most impactful savings approach is to focus on reducing the cost of frequent, predictable claims, an example is scheduled procedures. This highly variable “frequent claim layer” could easily range up 80% or 90% of the health insurance dollar for mid-sized employers. Increased data transparency provided by self-funding allows for more accurate identification and measurement of  claim frequency trends. The employer can then implement more targeted cost control initiatives.
Participation in a medical stop-loss group captive can smooth renewals and lower an employer’s medical benefit spend by spreading risk and applying the principals or risk pooling to enhance long-term rate stability. Surplus returned in the form of dividends serves to further reduce an employer’s cost of benefit delivery to employees.   
Donald McCully runs Medical Captive Underwriters LLC, (www.medicalcaptive.com).  A program management company focused on alternative risk transfer solutions to lower employer’s costs in both accident and health & property and casualty insurance.  Primary focus today is employee benefit advisors assisting them to lower medical spend and medical trend for employers enrolled in ClearCaptive.  ClearCaptive is a 50 state open, stop-loss captive solution for middle market employers above 50 employees enrolled on the Plan.
​
0 Comments

Employee paychecks further diluted by catastrophic medical and pharmacy (RX) claims over $1 million.

7/23/2019

0 Comments

 
Picture
Approximately 20% of the Gross Domestic Product (GDP) spending in the United States is devoted to healthcare; and increasing catastrophic claims costs, specifically over $1 million are a prime reason.  Instances of multi-million dollar individual claims have grown at a 30% annual rate since the passage of the Affordable Care Act (ACA) and its mandate for unlimited lifetime benefit limits in health plans.  Hospitals and pharmaceutical companies are reaping generous rewards that result from this “unlimited mandate”. The pricing authority now vested in hospitals and pharmaceutical companies is untenable and made worse by their unwillingness to provide any cost transparency to plan sponsors before or after medical events.  Prior to the ACA, plan sponsors would cap their annual or lifetime limit; a $1 million per member limit was considered the industry standard.  

Industry data reveals that claims over $1 million are primarily comprised of three conditions: Perinatal/Neonatal claims represent 20.7% of all claims and 22.2% of claims spend; Malignant Neoplasms/Cancers represent 20.7% of claims and 20.1% of the claims spend, and; Injury/Poisoning/External Causes, including Burns and Trauma, represent 12.6% of the number of claims and 11.0% of the claim spend.  
Opaque provider network contracts impede plan sponsors from their objective of implementing risk reduction initiatives targeted at containing medical claims costs. Networks consider their provider contracts to be “proprietary” despite Employee Retirement Income Security Act (ERISA) provisions deeming claims data ownership to the plan sponsor.  Claims detail is restricted by the networks hiding behind unreasoned arguments that make the plan sponsor’s ability to negotiate the cost of care before or after treatment highly difficult and unlikely.

Plan sponsors purchasing stop loss coverage to secure their plan expect claims to be paid. Unbundled stop-loss carriers, those owned independently from the provider networks, have difficulty accurately predicting current or future claims costs without access to appropriate and transparent claims data. 

The leveraging impact of medical inflationary trend, which typically outpaces actual Consumer Price Index (CPI) inflation in the United States, is borne by the stop-loss carriers or passed on to plan sponsors.  Plan sponsors are left with few choices to absorb increased retention of unpredictable medical costs or pass a portion of the increase to their employees in the form of higher deductibles, coinsurance or increased premium contributions.  The impact of medical cost-shifting means employee net (take-home) pay is diluted.

Self-insured plan sponsors know that retaining the predictable (and budgetable) levels of medical claim risk and buying medical stop-loss insurance to transfer unpredictable, and potentially catastrophic, claim risk is the most efficient method for controlling costs.  Self-insured employers are uniquely empowered with the ability to design plans that deliver greater transparency and increased control over medical costs. Participation in a group stop loss captive further enhances a self-insured employer’s ability by leveraging the strength of collective membership to capitalize on increased control. 

Donald McCully runs Medical Captive Underwriters LLC, (www.medicalcaptive.com).  A program management company focused on alternative risk transfer solutions to lower employer’s costs in both accident and health & property and casualty insurance.  Primary focus today is employee benefit advisors assisting them to lower medical spend and medical trend for employers enrolled in ClearCaptive. ClearCaptive is a 50 state open, stop-loss captive solution for middle market employers above 50 employees enrolled on the Plan
0 Comments

How Do You Stop Profit Leaks Due to Healthcare Inflation?

7/11/2019

 
Picture
Plumbers stop water leaks, but how do you stop profit leaks due to healthcare inflation? 

​
When evidence of water infiltration arrives in your house, the solution resides with a plumber.  Prior to service the plumber will identify the items you will pay for and the cost for each, such as:  travel time and  labor and materials.  A Contract will be signed upon the plumber’s arrival and the agreement is clearly understood by both parties.
​
Continuously increasing healthcare costs drain an employer’s hard-earned profits.  Traditional fully-funded or level-funded insurance programs provide no real transparency on healthcare cost drivers.  Increased cost-shifting in the form of higher deductibles and coinsurance reduces employee total compensation. This adversely impacts employee morale along with the employer’s ability to recruit and retain quality employees and impedes the employer’s business objectives.  

Self-funding is the solution to stop profit leakage for middle-market employers. 
More than 70% of all employer sponsored healthcare in the US is self-funded.   Self-funding increases an employer’s control over plan design and allows an employer to deliver healthcare benefits that more closely coincide with the firm’s financial, risk, and employee benefit objectives. Self-funding also improves transparency in terms of identifying specific cost drivers and claim trends within the plan and allows the employer to implement targeted risk mitigation initiatives. Self-funded employers also experience impactful cost reductions in insurance carrier overhead, reduced state premium taxes and avoidance of some ACA-mandated assessments. Employer plan sponsors contract with a Third-Party Administrator to provide medical and pharmacy benefit administration, under the employer’s direction, for covered members.   Medical stop loss coverage is purchased by the employer to stabilize the plan against large individual claims or an unusual accumulation of claims attributable to the entire population of enrolled plan members. Human resource can focus on attracting the talent pool your company seeks and engaging employees based on your core operational values.

Capitalizing on control: Group Stop Loss Captives 
Middle-market employers, those with 50-500 employees, can also take advantage of pooling principles and the law of large numbers by participating in a medical stop-loss group captive.  By collectively replicating the risk profile of a much larger entity, medical stop-loss group captives are able to reduce the effects of medical inflationary trend and promote overall cost stability by spreading risk across a larger grouping of participants. 

Considerations for selecting a captive program
Well run captive programs will provide complete transparency as to administrative and operational  fixed costs that are part of the employer’s indirect participation expenses in the captive. Any participation bylaws that the captive requires or the employer to remain in the program, either time or cost impact, should also be clearly outlined up front. The impact of fixed versus variable cost increases and the ability to lower medical spend should be reflected in the program’s published financial results.
Supply and demand principles do not impact medical inflation due to hospitals lack of transparency.  The solution for combating the negative impact of healthcare cost leaks on employer profits resides in self-funding.  The middle market employer’s best and most efficient method is the stop-loss group captive.

Don McCully runs Medical Captive Underwriters LLC, (www.medicalcaptive.com).  A program management company focused on alternative risk transfer solutions to lower employer’s costs in both accident and health & property and casualty insurance.  Primary focus today is employee benefit advisors assisting them to lower medical spend and medical trend for employers enrolled in ClearCaptive. ClearCaptive is a 50 state open, stop-loss captive solution for middle market employers above 50 employees enrolled on the Plan.

    Archives

    October 2019
    September 2019
    August 2019
    July 2019

    Categories

    All

    RSS Feed

medical captive underwriters, llc

Don McCully
703-966-9797
don@medicalcaptive.com
Website by RyTech, LLC